Stallion India

Who are the top shareholders of the Stallion India?

The top shareholder of Stallion India is Shazad Sheriar Rustomji, holding 67.88% of the shares. Other shareholders include 12 Foreign Institutional Investors with 3.32%, Geetu Yadav as the highest public shareholder at 4.16%, and individual investors holding 16.94%, with no pledged promoter holdings or mutual funds involved.

The top shareholders of Stallion India are primarily the promoters, with Shazad Sheriar Rustomji holding the largest share at 67.88%. In addition to the promoters, there are 12 Foreign Institutional Investors (FIIs) collectively holding 3.32% of the company. The highest public shareholder is Geetu Yadav, who owns 4.16%. Individual investors account for 16.94% of the total shareholding. Notably, there are no pledged promoter holdings and no mutual funds currently holding shares in the company.

Has Stallion India declared dividend?

No Dividend History Available

Who are the peers of the Stallion India?

Stallion India's peers include Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen. Key insights show varying management risks, growth rates, and capital structures among these companies, with Refex Industries leading in 1-year returns at 270.26% and Linde India having the lowest at -15.03%.

Peers: The peers of Stallion India are Solar Industries, Linde India, PCBL Chemical, Refex Industries, Prem. Explosives, DIC India, Keltech Energies, Beezaasan Exp., and Natl. Oxygen.<BR><BR>Quality Snapshot: Excellent management risk is observed at Solar Industries, while Good management risk is found at Linde India and PCBL Chemical, and Average management risk is present at Refex Industries, Prem. Explosives, Stallion India, DIC India, Keltech Energies, and Beezaasan Exp. Excellent growth is seen at Solar Industries, PCBL Chemical, and Refex Industries, while Good growth is noted at Prem. Explosives and Beezaasan Exp., Average growth is found at Keltech Energies, and Below Average growth is present at Linde India and DIC India. Excellent capital structure is attributed to Solar Industries, Refex Industries, and Stallion India, while Average capital structure is seen at PCBL Chemical, and Good capital structure is noted at DIC India and Keltech Energies, with Below Average capital structure at Prem. Explosives and Natl. Oxygen.<BR><BR>Return Snapshot: Refex Industries has the highest 1-year return at 270.26%, while Linde India has the lowest at -15.03%. Stallion India's 1-year return is not available for comparison. Additionally, Linde India and DIC India have negative six-month returns.

What does Stallion India do?

Stallion India Fluorochemicals Ltd, a Micro Cap company established in 2002, operates in the Other Chemical products industry and reported net sales of 1,516 Cr and a net profit of 133 Cr for the quarter ending March 2025. The company has a market cap of INR 823 Cr and a P/E ratio of 25.00.

Overview: <BR>Stallion India Fluorochemicals Ltd operates in the Other Chemical products industry and is categorized as a Micro Cap company.<BR><BR>History: <BR>The company was incorporated in 2002 as a Private Limited Company in Mumbai and later converted to a Public Limited Company, with the name changed to Stallion India Fluorochemicals Limited on October 05, 2023. The most recent quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot: <BR>Most recent Net Sales: 1,516 Cr (Quarterly Results - Mar 2025) <BR>Most recent Net Profit: 133 Cr (Quarterly Results - Mar 2025) <BR>Market-cap value: INR 823 Cr (Micro Cap)<BR><BR>Key Metrics: <BR>P/E: 25.00 <BR>Industry P/E: 47 <BR>Dividend Yield: 0.00% <BR>Debt-Equity: -0.24 <BR>Return on Equity: 10.75% <BR>Price to Book: 2.65 <BR><BR>Contact Details: <BR>No Company Details Available <BR>Registrar Address: Not available.

How big is Stallion India?

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, with recent net sales of 304.28 Cr and a net profit of 23.91 Cr. The company's shareholder's funds are 117.96 Cr, and total assets amount to 202.40 Cr.

As of 24th July, Stallion India Fluorochemicals Ltd has a market capitalization of 929.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Stallion India reported Net Sales of 304.28 Cr and a Net Profit of 23.91 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, showing Shareholder's Funds of 117.96 Cr and Total Assets of 202.40 Cr.

How has been the historical performance of Stallion India?

Stallion India has shown significant growth over the past three years, with net sales increasing from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, and profit after tax rising from 9.75 Cr to 32.33 Cr, reflecting strong operational efficiency and profitability. Total assets also grew substantially, indicating robust financial performance across key metrics.

Answer:<BR>The historical performance of Stallion India shows significant growth in various financial metrics over the past three years.<BR><BR>Breakdown:<BR>Stallion India's net sales increased from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25, indicating a strong upward trend. Total operating income followed suit, rising from 225.50 Cr in Mar'23 to 377.45 Cr in Mar'25. The company's total expenditure also grew, from 210.46 Cr in Mar'23 to 329.73 Cr in Mar'25, primarily driven by raw material costs, which surged from 195.58 Cr to 292.95 Cr during the same period. Operating profit (PBDIT) saw a substantial rise from 15.60 Cr in Mar'23 to 49.74 Cr in Mar'25, reflecting improved operational efficiency. Profit before tax increased from 12.97 Cr to 42.43 Cr, while profit after tax rose from 9.75 Cr to 32.33 Cr, showcasing a robust growth in profitability. The earnings per share (EPS) also improved significantly, from 1.77 in Mar'23 to 4.08 in Mar'25. On the balance sheet, total assets grew from 125.43 Cr in Mar'23 to 327.21 Cr in Mar'25, with total liabilities increasing from 125.43 Cr to 327.21 Cr as well. The cash flow from financing activities remained positive, contributing to a net cash inflow of 42.00 Cr in Mar'25, up from 15.00 Cr in Mar'24. Overall, Stallion India has demonstrated a strong financial performance with consistent growth across key metrics.

Is Stallion India overvalued or undervalued?

As of November 26, 2025, Stallion India is considered overvalued with a PE ratio of 45.93, an EV to EBITDA of 29.40, and a PEG ratio of 0.00, significantly higher than its peers and has underperformed against the Sensex with a 1-month return of -41.72%.

As of 26 November 2025, Stallion India has moved from a valuation grade of very expensive to expensive. The company is currently considered overvalued. Key ratios include a PE ratio of 45.93, an EV to EBITDA of 29.40, and a ROCE of 19.73%. <BR><BR>In comparison to its peers, Stallion India's PE ratio is significantly higher than Godrej Industries, which stands at 36.8, and Deepak Nitrite at 40.22. The PEG ratio for Stallion is 0.00, indicating no growth expectations priced into the stock, which is concerning given its high valuation. Additionally, Stallion India has underperformed against the Sensex, with a 1-month return of -41.72% compared to the Sensex's 1.66% return, further reinforcing the notion that the stock may be overvalued.

When is the next results date for Stallion India Fluorochemicals Ltd?

The next results date for Stallion India Fluorochemicals Ltd is 13 May 2026.

The next results date for Stallion India Fluorochemicals Ltd is scheduled for 13 May 2026.

Are Stallion India Fluorochemicals Ltd latest results good or bad?

Stallion India Fluorochemicals Ltd's latest results are mixed, with a net profit decline of 17.64% year-on-year and a significant revenue drop of 27.43%, raising concerns about demand sustainability. While there was a 40.08% profit growth over nine months, the sharp revenue contraction and stock decline indicate investor skepticism about future growth.

The latest results for Stallion India Fluorochemicals Ltd indicate a mixed performance. In Q4 FY26, the company reported a net profit of ₹10.93 crores, which is a decline of 17.64% year-on-year and a slight decrease of 1.80% quarter-on-quarter. Revenue for the same quarter was ₹109.99 crores, reflecting a significant year-on-year decline of 27.43%, although it showed a modest sequential growth of 5.10%.<BR><BR>While the operating margin improved to 14.86%, up 370 basis points from the previous quarter, the overall revenue contraction raises concerns about the sustainability of demand. The company's stock has also seen a dramatic decline of 61.13% from its 52-week high, reflecting investor apprehension regarding its growth prospects in a competitive market.<BR><BR>On a more positive note, the nine-month performance for FY26 showed a net profit growth of 40.08% compared to the previous year, indicating some resilience in the business. However, the elevated valuation metrics, with a P/E ratio of 35.23 and a price-to-book ratio of 5.12, suggest limited room for error in execution.<BR><BR>Overall, the results can be characterized as concerning, particularly due to the sharp revenue decline and the market's reaction, which reflects skepticism about the company's ability to maintain its growth trajectory. Investors should be cautious and monitor upcoming quarters for signs of stabilization and recovery.

Should I buy, sell or hold Stallion India Fluorochemicals Ltd?

Why is Stallion India Fluorochemicals Ltd falling/rising?

As of 19-May, Stallion India Fluorochemicals Ltd's stock price has risen to 166.35, reflecting a 16.33% increase. This growth is driven by strong recent performance, outperforming its sector and the Sensex, although a decline in investor participation may raise future trading concerns.

As of 19-May, Stallion India Fluorochemicals Ltd is experiencing a rise in its stock price, currently at 166.35, which reflects an increase of 23.35 or 16.33%. This upward movement can be attributed to several factors. The stock has outperformed its sector by 15.56% today and has shown a strong performance over the last three days, gaining 20.89% in that period. Additionally, it has been trading above its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages, indicating a positive trend in its price movement.<BR><BR>In the past week, the stock has risen by 13.09%, significantly outperforming the Sensex, which only increased by 0.86%. Furthermore, over the past year, Stallion India has seen a remarkable increase of 144.69%, while the Sensex has declined by 8.36%. However, it is important to note that there has been a decline in investor participation, with delivery volume dropping by 47.86% compared to the 5-day average, which could indicate a potential concern for future trading activity. Despite this, the current momentum and recent performance suggest a strong upward trajectory for the stock at this time.

Which are the latest news on Stallion India?